FDA Whistleblower Letter Released At Sebelius Confirmation Hearing
This article was originally published in The Gray Sheet
Executive Summary
Nine FDA scientists urge "sweeping measures" and harsh disciplinary action within the agency in an April 2 1letter to President Obama that was publicly disclosed during a confirmation hearing for the likely next secretary of the Department of Health and Human Services
You may also be interested in...
Radiology Devices Move To OIVD: More Cohesive Dx Reviews Ahead?
FDA hopes that shuttling its Radiological Devices Branch to the Office of In Vitro Diagnostic Device Evaluation and Safety will produce more cohesive policies on diagnostic device review
Radiology Devices Move To OIVD: More Cohesive Dx Reviews Ahead?
FDA hopes that shuttling its Radiological Devices Branch to the Office of In Vitro Diagnostic Device Evaluation and Safety will produce more cohesive policies on diagnostic device review
FDA Refines Requirements For Computer-Aided Detection
FDA published two draft guidance documents Oct. 21 to help firms through 510(k) or PMA submissions for computer-aided detection tools; on the following day, the agency announced an upcoming panel meeting on the topic